Achieving vascular risk factor targets: a survey of a London general practice

Adam P Levine1, Dimitri P Mikhailidis, Tessa Moross

  • 1The Crouch Hall Road Surgery, Hornsey, United Kingdom.

Angiology
|March 6, 2008
PubMed

Insights

Achieving stricter lipid targets for vascular event prevention remains challenging for many patients on statin therapy. While some guidelines are met, others require improved strategies like combination therapy or dose adjustments.

Area of Science:

  • Cardiology
  • General Practice
  • Pharmacology

Background:

  • Patients at high risk for vascular events require effective lipid management.
  • Statin therapy is a cornerstone in managing dyslipidemia and preventing cardiovascular events.
  • General practices play a crucial role in implementing and monitoring lipid-lowering treatments.

Purpose of the Study:

  • To assess the achievement of lipid goals in high-risk patients treated in a general practice setting.
  • To evaluate the effectiveness of statin therapy in reaching various lipid targets.
  • To identify factors influencing lipid goal attainment and potential areas for improvement.

Main Methods:

  • Retrospective analysis of patient data from a London general practice.
  • Identification of high-risk patients based on hypolipidaemic medication, Framingham risk score, and myocardial infarction register.
  • Assessment of lipid profiles (total cholesterol, LDL-C, HDL-C, triglycerides) before and after statin treatment.

Main Results:

  • Significant improvements in cholesterol, HDL-C, LDL-C, and triglycerides were observed post-statin treatment.
  • Only 29.1% of patients reached the Joint British Societies' Guidelines total cholesterol target (<4.0 mmol/L).
  • 38.8% achieved the low-density lipoprotein-cholesterol target (<2.0 mmol/L), similar to AHA/ACC recommendations.
  • 73.6% met the less stringent General Medical Services total cholesterol target (<=5.0 mmol/L).
  • Patients with comorbidities showed better achievement of cholesterol targets.

Conclusions:

  • While General Medical Services lipid targets were largely met, Joint British Societies' Guidelines targets were not.
  • Current stricter lipid targets pose a challenge for achievement in routine general practice.
  • Strategies such as combination therapy, statin dose titration, and enhanced patient education may improve lipid goal attainment.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...